| abstract |
An object of the present invention is to provide a body cavity fluid retention inhibitor that has a medicinal effect on body cavity fluid retention in which a therapeutic effect is not obtained even when a diuretic is administered, and that can exert a therapeutic effect even when administered systemically. . The present invention provides a body cavity fluid retention inhibitor containing a covalent conjugate of interferon and polyalkylene glycol as an active ingredient. |